The role of exercise in modifying outcomes for people with multiple sclerosis: A randomized trial

Nancy E. Mayo, Mark Bayley, Pierre Duquette, Yves Lapierre, Ross Anderson, Susan Bartlett

Research output: Contribution to journalArticle

Abstract

Background: Despite the commonly known benefits of exercise and physical activity evidence shows that persons Multiple Sclerosis (MS) are relatively inactive yet physical activity may be even more important in a population facing functional deterioration. No exercise is effective if it is not done and people with MS face unique barriers to exercise engagement which need to be overcome. We have developed and pilot tested a Multiple Sclerosis Tailored Exercise Program (MSTEP) and it is ready to be tested against general guidelines for superiority and ultimately for its impact on MS relevant outcomes. The primary research question is to what extent does an MS Tailored Exercise Program (MSTEP) result in greater improvements in exercise capacity and related outcomes over a one year period in comparison to a program based on general guidelines for exercise among people with MS who are sedentary and wish to engage in exercise as part of MS self-management.Methods/Design: The proposed study is an assessor-blind, parallel-group, randomized controlled trial (RCT). The duration of the intervention will be one year with follow-up to year two. The targeted outcomes are exercise capacity, functional ambulation, strength, and components of quality of life including frequency and intensity of fatigue symptoms, mood, global physical function, health perception, and objective measures of activity level. Logistic regression will be used to test the main hypothesis related to the superiority of the MSTEP program based on a greater proportion of people making a clinically relevant gain in exercise capacity at 1 year and at 2 years, using an intention-to-treat approach. Sample size will be 240 (120 per group).Discussion: The MS community is clearly looking for interventions to help alleviate the disabling sequelae of MS and promote health. Exercise is a well-known intervention which has known benefits to all, yet few exercise regularly. For people with MS, the role of exercise in MS management needs to be rigorously assessed to inform people as to how best to use exercise to reduce disability and promote health.Trial registration: Clinical Trials.gov: NCT01611987.

Original languageEnglish (US)
Article number69
JournalBMC Neurology
Volume13
DOIs
StatePublished - Jun 28 2013
Externally publishedYes

Fingerprint

Multiple Sclerosis
Health
Guidelines
Self Care
Sample Size
Walking
Fatigue
Randomized Controlled Trials
Logistic Models
Quality of Life
Clinical Trials

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Mayo, N. E., Bayley, M., Duquette, P., Lapierre, Y., Anderson, R., & Bartlett, S. (2013). The role of exercise in modifying outcomes for people with multiple sclerosis: A randomized trial. BMC Neurology, 13, [69]. https://doi.org/10.1186/1471-2377-13-69

The role of exercise in modifying outcomes for people with multiple sclerosis : A randomized trial. / Mayo, Nancy E.; Bayley, Mark; Duquette, Pierre; Lapierre, Yves; Anderson, Ross; Bartlett, Susan.

In: BMC Neurology, Vol. 13, 69, 28.06.2013.

Research output: Contribution to journalArticle

Mayo, Nancy E. ; Bayley, Mark ; Duquette, Pierre ; Lapierre, Yves ; Anderson, Ross ; Bartlett, Susan. / The role of exercise in modifying outcomes for people with multiple sclerosis : A randomized trial. In: BMC Neurology. 2013 ; Vol. 13.
@article{0268fca6197f413ba19b01243ecdc7e7,
title = "The role of exercise in modifying outcomes for people with multiple sclerosis: A randomized trial",
abstract = "Background: Despite the commonly known benefits of exercise and physical activity evidence shows that persons Multiple Sclerosis (MS) are relatively inactive yet physical activity may be even more important in a population facing functional deterioration. No exercise is effective if it is not done and people with MS face unique barriers to exercise engagement which need to be overcome. We have developed and pilot tested a Multiple Sclerosis Tailored Exercise Program (MSTEP) and it is ready to be tested against general guidelines for superiority and ultimately for its impact on MS relevant outcomes. The primary research question is to what extent does an MS Tailored Exercise Program (MSTEP) result in greater improvements in exercise capacity and related outcomes over a one year period in comparison to a program based on general guidelines for exercise among people with MS who are sedentary and wish to engage in exercise as part of MS self-management.Methods/Design: The proposed study is an assessor-blind, parallel-group, randomized controlled trial (RCT). The duration of the intervention will be one year with follow-up to year two. The targeted outcomes are exercise capacity, functional ambulation, strength, and components of quality of life including frequency and intensity of fatigue symptoms, mood, global physical function, health perception, and objective measures of activity level. Logistic regression will be used to test the main hypothesis related to the superiority of the MSTEP program based on a greater proportion of people making a clinically relevant gain in exercise capacity at 1 year and at 2 years, using an intention-to-treat approach. Sample size will be 240 (120 per group).Discussion: The MS community is clearly looking for interventions to help alleviate the disabling sequelae of MS and promote health. Exercise is a well-known intervention which has known benefits to all, yet few exercise regularly. For people with MS, the role of exercise in MS management needs to be rigorously assessed to inform people as to how best to use exercise to reduce disability and promote health.Trial registration: Clinical Trials.gov: NCT01611987.",
author = "Mayo, {Nancy E.} and Mark Bayley and Pierre Duquette and Yves Lapierre and Ross Anderson and Susan Bartlett",
year = "2013",
month = "6",
day = "28",
doi = "10.1186/1471-2377-13-69",
language = "English (US)",
volume = "13",
journal = "BMC Neurology",
issn = "1471-2377",
publisher = "BioMed Central",

}

TY - JOUR

T1 - The role of exercise in modifying outcomes for people with multiple sclerosis

T2 - A randomized trial

AU - Mayo, Nancy E.

AU - Bayley, Mark

AU - Duquette, Pierre

AU - Lapierre, Yves

AU - Anderson, Ross

AU - Bartlett, Susan

PY - 2013/6/28

Y1 - 2013/6/28

N2 - Background: Despite the commonly known benefits of exercise and physical activity evidence shows that persons Multiple Sclerosis (MS) are relatively inactive yet physical activity may be even more important in a population facing functional deterioration. No exercise is effective if it is not done and people with MS face unique barriers to exercise engagement which need to be overcome. We have developed and pilot tested a Multiple Sclerosis Tailored Exercise Program (MSTEP) and it is ready to be tested against general guidelines for superiority and ultimately for its impact on MS relevant outcomes. The primary research question is to what extent does an MS Tailored Exercise Program (MSTEP) result in greater improvements in exercise capacity and related outcomes over a one year period in comparison to a program based on general guidelines for exercise among people with MS who are sedentary and wish to engage in exercise as part of MS self-management.Methods/Design: The proposed study is an assessor-blind, parallel-group, randomized controlled trial (RCT). The duration of the intervention will be one year with follow-up to year two. The targeted outcomes are exercise capacity, functional ambulation, strength, and components of quality of life including frequency and intensity of fatigue symptoms, mood, global physical function, health perception, and objective measures of activity level. Logistic regression will be used to test the main hypothesis related to the superiority of the MSTEP program based on a greater proportion of people making a clinically relevant gain in exercise capacity at 1 year and at 2 years, using an intention-to-treat approach. Sample size will be 240 (120 per group).Discussion: The MS community is clearly looking for interventions to help alleviate the disabling sequelae of MS and promote health. Exercise is a well-known intervention which has known benefits to all, yet few exercise regularly. For people with MS, the role of exercise in MS management needs to be rigorously assessed to inform people as to how best to use exercise to reduce disability and promote health.Trial registration: Clinical Trials.gov: NCT01611987.

AB - Background: Despite the commonly known benefits of exercise and physical activity evidence shows that persons Multiple Sclerosis (MS) are relatively inactive yet physical activity may be even more important in a population facing functional deterioration. No exercise is effective if it is not done and people with MS face unique barriers to exercise engagement which need to be overcome. We have developed and pilot tested a Multiple Sclerosis Tailored Exercise Program (MSTEP) and it is ready to be tested against general guidelines for superiority and ultimately for its impact on MS relevant outcomes. The primary research question is to what extent does an MS Tailored Exercise Program (MSTEP) result in greater improvements in exercise capacity and related outcomes over a one year period in comparison to a program based on general guidelines for exercise among people with MS who are sedentary and wish to engage in exercise as part of MS self-management.Methods/Design: The proposed study is an assessor-blind, parallel-group, randomized controlled trial (RCT). The duration of the intervention will be one year with follow-up to year two. The targeted outcomes are exercise capacity, functional ambulation, strength, and components of quality of life including frequency and intensity of fatigue symptoms, mood, global physical function, health perception, and objective measures of activity level. Logistic regression will be used to test the main hypothesis related to the superiority of the MSTEP program based on a greater proportion of people making a clinically relevant gain in exercise capacity at 1 year and at 2 years, using an intention-to-treat approach. Sample size will be 240 (120 per group).Discussion: The MS community is clearly looking for interventions to help alleviate the disabling sequelae of MS and promote health. Exercise is a well-known intervention which has known benefits to all, yet few exercise regularly. For people with MS, the role of exercise in MS management needs to be rigorously assessed to inform people as to how best to use exercise to reduce disability and promote health.Trial registration: Clinical Trials.gov: NCT01611987.

UR - http://www.scopus.com/inward/record.url?scp=84879438948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879438948&partnerID=8YFLogxK

U2 - 10.1186/1471-2377-13-69

DO - 10.1186/1471-2377-13-69

M3 - Article

C2 - 23809312

AN - SCOPUS:84879438948

VL - 13

JO - BMC Neurology

JF - BMC Neurology

SN - 1471-2377

M1 - 69

ER -